Quick Answer
OCULAR THERAPEUTIX, INC reported Operating Income of -$270.02 million for fiscal year 2025.
OCULAR THERAPEUTIX, INC Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$270.02M | -57.2% |
| 2024 | -$171.78M | -108.5% |
| 2023 | -$82.38M | -4.7% |
| 2022 | -$78.65M | -0.8% |
| 2021 | -$78.04M | -24.2% |
| 2020 | -$62.85M | +26.8% |
| 2019 | -$85.80M | -45.1% |
| 2018 | -$59.12M | +4.5% |
| 2017 | -$61.92M | -42.9% |
| 2016 | -$43.33M | -13.4% |
| 2015 | -$38.20M | -41.0% |
| 2014 | -$27.09M | -110.0% |
| 2013 | -$12.90M | +5.6% |
| 2012 | -$13.67M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$68.70M | -49.3% | -1.6% |
| June 30, 2025 | -$67.64M | -55.2% | -5.8% |
| March 31, 2025 | -$63.92M | -102.2% | -39.0% |
| September 30, 2024 | -$46.00M | -139.4% | -5.5% |
| June 30, 2024 | -$43.59M | -111.9% | -37.9% |
| March 31, 2024 | -$31.62M | -40.2% | -64.6% |
| September 30, 2023 | -$19.21M | +10.8% | +6.6% |
| June 30, 2023 | -$20.57M | -3.3% | +8.8% |
- OCULAR THERAPEUTIX, INC showed a decrease of -57.2% in Operating Income compared to the prior fiscal year.
- Over the 2012–2025 period, OCULAR THERAPEUTIX, INC’s operating income has declined by 1875.1% (from -$13.67 million to -$270.02 million).
- The most recent figure is from OCULAR THERAPEUTIX, INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: